Acid-base balance study for ICU patients
Part of Infections clinical trials.
This study looks at acid-base problems in patients admitted to the intensive care unit (ICU). It aims to understand these issues better, which could help improve care for patients with similar conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the intensive care unit (ICU).
- You have a documented acid-base imbalance (a problem with the acid level in your blood).
- Your medical records are complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how doctors treat septic shock in the ICU to learn what works best. If you have septic shock, joining this study helps researchers understand which treatments are most effective, and you'll get the same care you would anyway.
This study looks at the bacteria in the gut of patients with sepsis in the ICU. It aims to understand how these bacteria change during critical illness, which could lead to better treatments.
This study looks at how often metabolic acidosis (too much acid in the blood) occurs in children in the intensive care unit. It aims to understand this condition better to improve care.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
Hear when a new Septicemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.